Generic Product News (September 2015)

Publication
Article
Pharmacy TimesSeptember 2015 Specialty Pharmacy
Volume 81
Issue 9

Read about the new generic products featured in September.

Divalproex Sodium Extended—Release TabletsMarketed by: Amneal Pharmaceuticals

Compare to: Depakote ER (AbbVie Inc)

Indication: Amneal Pharmaceuticals has launched Divalproex Sodium Extended- Release Tablets, a generic version of AbbVie’s Depakote ER, to treat patients with epilepsy. It is also indicated as an acute treatment for manic or mixed episodes associated with bipolar disorder and as adjunctive therapy in patients with multiple seizure types.

Dosage Form: Tablets: 250 mg and 500 mg

For More Information: www.amneal.com

Megestrol Acetate Oral Suspension, USPMarketed by: TWi Pharmaceuticals, Inc

Compare to: Megace ES (Par Pharmaceutical)

Indication: TWi Pharmaceuticals has launched Megestrol Acetate Oral Suspension, a generic equivalent to Par Pharmaceutical’s Megace ES. Megestrol acetate is indicated to treat patients experiencing appetite loss, severe malnutrition, or unexplained substantial weight loss associated with AIDS.

Dosage Form: Concentrated formula: 625 mg/5 mL

For More Information: www.twipharma.com

Memantine Tydrochloride Tablets USPMarketed by: Mylan NV

Compare to: Namenda (Forest Laboratories)

Indication: Mylan NV has launched Memantine Tydrochloride Tablets USP, a generic version of Forest Laboratories’ Namenda tablets, in 5-mg and 10-mg tablet strengths. The product is indicated to treat moderate to severe dementia associated with Alzheimer’s disease.

Dosage Form: Tablets: 5 mg and 10 mg

For More Information: www.mylan.com

Tobramycin Inhalation SolutionMarketed by: Amneal Pharmaceuticals

Compare to: Tobi (Novartis)

Indication: Amneal Pharmaceuticals has launched Tobramycin Inhalation Solution, a generic version of Tobi by Novartis. It is indicated for managing patients with cystic fibrosis who are infected with Pseudomonas aeruginosa.

Dosage Form: Inhalation solution: 300 mg/5 mL

For More Information: www.amneal.com

Lidocaine Patch 5%Marketed by: Mylan

Compare to: Lidoderm (Endo Pharmaceuticals)

Indication: Lidocaine Patch 5% is indicated to treat pain associated with postherpetic neuralgia and is the generic equivalent to Endo Pharmaceuticals’ Lidoderm. The topical product comes in the form of a lightweight, thin patch and serves as a local anesthetic.

Dosage Form: Patch

For More Information: www.mylan.com

Aripiprazole Oral SolutionMarketed by: Amneal Pharmaceuticals

Compare to: Abilify Oral Solution (Otsuka America Pharmaceutical, Inc)

Indication: Aripiprazole Oral Solution is an atypical antipsychotic that is indicated to treat schizophrenia and manic and mixed episodes associated with bipolar I, and as an adjunctive treatment of major depressive disorder. It should be administered once daily without regard to meals. It is the generic equivalent to the now-discontinued Abilify Oral Solution.

Dosage Form: Oral solution: 1 mg/mL

For More Information: www.amneal.com

Esomeprazole Magnesium Delayed-Release Capsules USP Marketed by: Mylan

Compare to: Nexium (AstraZeneca)

Indication: Esomeprazole Magnesium Delayed-Release Capsules USP is a proton- pump inhibitor indicated for the treatment of gastroesophageal reflux disease (GERD) in adults and children 1 year and older. Esomeprazole is also indicated to maintain symptom resolution and healing of erosive esophagitis and for the short-term treatment of heartburn and other symptoms associated with GERD. It is the generic equivalent of AstraZeneca’s Nexium.

Dosage Form: Capsules: 20 mg and 40 mg

For More Information: www.mylan.com

Drospirenone and Ethinyl Estradiol Tablets USPMarketed by: Glenmark Pharmaceuticals Ltd

Compare to: Yaz (Bayer Healthcare)

Indication: Glenmark Pharmaceuticals Ltd has received final approval for Drospirenone and Ethinyl Estradiol Tablets USP, the generic equivalent to Bayer Healthcare’s oral contraceptive Yaz. It is a progesterone and estrogen combination birth control pill that works by preventing ovulation, thickening the mucus in the cervix, and changing the lining of the uterus. It is also indicated to treat premenstrual dysphoric disorder or certain types of acne in women who are using it for birth control.

Dosage Form: Tablets: 3 mg/0.02 mg

For More Information: www.glenmarkpharma.com

Related Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs
© 2024 MJH Life Sciences

All rights reserved.